Medication
1.0.0 - STU1
This page is part of the HL7 Belgium FHIR Implementation Guide - Medication profiles (v1.0.0: Trial Use) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Requirements:
Requirement | |
---|---|
R1 | Medication information may include detailed process information (e.g. prescriptions and dispenses, with detailed traceability information), or summary information such as that reported by a patient or by a GP. |
R2 | Medication information may be processed, for example aggregated, reconciled, etc. and this should be exchanged transparently |
R3 | The aggregation of medication information may be done differently, with different rules For example, medications may be aggregated by the active principle, or by active principle and indication for a more granular view |
R4 | A prescription may be triggered by first defining and planning a treatment plan, or the treatment may be documented after a prescription or dispense. |
R5 | In different parts of the process, Medication may be represented differently For example, a medication is prescribed by its active principle, and a branded product is dispensed. |
R6 | Medication items can have a M:N relation type with indications |
R7 | Medication overviews may include different types of medication for example, some overviews may include vaccines, anesthetics, and OTPs, while others may exclude some of these. |
R8 | Medication overviews may include different periods For example, some overviews may include only the recent medication, while others may include the patient’s lifelong medication information |
R9 | The way that medication information is exchanged should capture the meaning of the information (e.g. whether the information is a prescription or a paient-reported summary), |
R10 | The medication exchange information should reflect the status, (e.g. from planned vs ongoing), but should be exchanged in a consistent way across the status For example, a medication that is planned but not yet prescribed should be summarized in a way that is consistent when it is prescribed, or reported by the patient |